World Health Organization. The Global Burden of Disease: 2004 Update. WHO, 2008.
National Institute for Health and Clinical Excellence. Costing statement: ‘Depression: the treatment and management of depression in adults (update)’ and ‘Depression in adults with a chronic physical health problem: treatment and management’. NICE, 2009 (http://www.nice.org.uk/nicemedia/live/12329/45943/45943.pdf).
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry
2006; 163: 28–40.
The economic impact of depression: resistance or severity?
2010; 20: 671–675.
Smith Carls, G
Cost burden of treatment resistance in patients with depression. Am J Manag Care
2010; 16: 370–377.
The cost consequences of treatment-resistant depression. J Clin Psychiatry
2004; 65: 341–347.
Economic implications of treatment-resistant depression among employees. Pharmacoeconomics
2004; 22: 363–373.
Cost-effectiveness of cognitive behaviour therapy in addition to mebeverine for irritable bowel syndrome. Eur J Gastroenterol Hepatol
2008; 20: 255–263.
Cost-effectiveness of relapse-prevention cognitive therapy for bipolar disorder: 30-month study. Br J Psychiatry
2005; 186: 500–506.
Cost effectiveness of cognitive behavioural therapy, graded exercise and usual care for patients with chronic fatigue in primary care. Psychol Med
2004; 34: 991–999.
Cost-effectiveness of computerised cognitive–behavioural therapy for anxiety and depression in primary care: randomised controlled trial. Br J Psychiatry
2004; 185: 55–62.
Cost-effectiveness of therapist-delivered online cognitive–behavioural therapy for depression: randomised controlled trial. Br J Psychiatry
2010; 197: 297–304.
Cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment resistant depression in primary care: the CoBalT randomised controlled trial protocol. Contemp Clin Trials
2012; 33: 312–319.
Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial. Lancet
2013; 381: 375–384.
National Institute for Health and Clinical Excellence. Guide to the Methods of Technology Appraisal 2008. NICE, 2008.
Beck Depression Inventory: Manual (2nd edn). The Psychological Corporation, 1996.
Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers. Psychol Med
1992; 22: 465–486.
Assessing psychiatric disorder with a human interview or a computer. J Epidemiol Community Health
1994; 48: 207–210.
Cognitive Therapy: Basics and Beyond. Guilford Press, 1995.
Cognitive Therapy of Depression. Wiley, 1979.
Cognitive Therapy for Chronic and Persistent Depression. John Wiley & Sons, 2003.
A 12-item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care
1996; 34: 220–233.
EuroQol: the current state of play. Health Policy
1996; 37: 53–72.
Cognitive–behavioural therapy for health anxiety in a genitourinary medicine clinic: randomised controlled trial. Br J Psychiatry
2008; 193: 332–337.
Unit Costs of Health and Social Care 2010. PSSRU, 2011.
Evaluation of NHS Direct First Wave Sites: Final Report of the Phase 1 Research. University of Sheffield, 2001.
Evaluation of the Introduction of NHS 24 in Scotland. University of Aberdeen, 2005.
Department of Health. 2010–11 Reference Costs Publication. Department of Health, 2011.
British Medical Association, Royal Pharmaceutical Society of Great Britain. British National Formulary 59. British Medical Association and Royal Pharmaceutical Society of Great Britain, 2010.
Office for National Statistics. 2010 Annual Survey of Hours and Earnings. ONS, 2011.
A Social Tariff for EuroQol: Results from a UK General Population Survey. Univeristy of York Working Paper 138. Centre for Health Economics, University of York, 1995.
Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ
2005; 14: 487–496.
van Buuren, S
Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med
1999; 18: 681–694.
Measuring and valuing mental health for use in economic evaluation. J Health Serv Res Policy
2008; 13: 70–75.
A randomised controlled trial of cognitive behavioural therapy as an adjunct to pharmacotherapy in primary care based patients with treatment resistant depression: a pilot study. Behav Cogn Psychother
2008; 36: 21–33.
SF-6D and EQ-5D result in widely divergent incremental cost-effectiveness ratios in a clinical trial of older women: implications for health policy decisions. Osteoporos Int
2012; 23: 1849–1857.
A comparison of the performance of the EQ-5D and SF-6D for individuals aged ⩾45 years. Health Econ
2008; 17: 815–832.
A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ
2004; 13: 873–884.
An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Econ
2003; 12: 1061–1067.
van Straten, A
Comparison of EQ-5D and SF-6D utilities in mental health patients. Health Econ
2006; 15: 1229–1236.
The clinical effectiveness and cost-effectiveness of low-intensity psychological interventions for the secondary prevention of relapse after depression: a systematic review. Health Technology Assess
2012; 28: 1–130.
Methods for the Estimation of the NICE Cost-Effectiveness Threshold. Research Paper 81. Centre for Health Economics, University of York, 2013.
Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD study. Health Technol Assess
2009; 22: 47–56.
Cost-effectiveness of an Improving Access to Psychological Therapies service. Br J Psychiatry
2013; 202: 220–227.
Direct and indirect costs of employees with treatment-resistant and non-treatment-resistant major depressive disorder. Curr Med Res Opin
2010; 26: 2475–2484.
How Mental Illness Loses Out in the NHS. Centre for Economic Performance, London School of Economics and Political Science, 2012.
Health at Work – An Independent Review of Sickness Absence. TSO (The Stationery Office), 2011.